ERBB2 and breast carcinoma: The immunosuppressive M2 TAMs are the most abundant in breast cancer [49], and a high presence is associated with higher tumor grade, ER and PR negativity, and a shorter overall survival, especially in HER2+ and TNBC [50–52].